Progress of response evaluation and prognosis in chronic lymphocytic leukemia:reports from the 56th American Society of Hematology annual meeting
10.3760/cma.j.issn.1009-9921.2015.01.007
- VernacularTitle:慢性淋巴细胞白血病疗效评估和预后研究进展:第56届美国血液学会年会报道
- Author:
Ying HUANG
;
Lei FAN
;
Wei XU
;
Jianyong LI
- Publication Type:Journal Article
- Keywords:
Chronic lymphocytic leukemia;
Response evaluation;
Prognosis;
American Society of Hematology annual meeting
- From:
Journal of Leukemia & Lymphoma
2015;24(1):20-22
- CountryChina
- Language:Chinese
-
Abstract:
Chronic lymphocytic leukemia (CLL) is an incurable B cell chronic lymphoproliferative disorder with a highly heterogeneous clinical course.The malignant B lymphocytes that have a mature appearance infiltrate in to lymph node,bone marrow,liver and spleen.The 56th American Society of Hematology (ASH) annual meeting explored multiple aspects including pathogenesis,treatment,response evaluation and prognosis of CLL.Clinical outcome of CLL patients can be predicted more accurately by a series of novel markers such as minimal residual disease.The progress of response evaluation and prognosis in CLL were focused in this review.
